149 filings
8-K
CC
Chemours Company
28 Mar 24
Regulation FD Disclosure
8:18pm
8-K
CC
Chemours Company
27 Mar 24
Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review
6:12pm
8-K
CC
Chemours Company
27 Mar 24
The Chemours Company Reports Fourth Quarter and Full Year 2023 Results
6:09pm
8-K
CC
Chemours Company
26 Mar 24
2023 Form 10-K Filing and Webcast Conference Call
5:30pm
8-K
CC
Chemours Company
25 Mar 24
Chemours Announces Appointment of Denise Dignam as President
6:04am
8-K
1e2 5p4sfk
18 Mar 24
Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing
6:32pm
8-K
fg3k3kkeztzk6sdh
6 Mar 24
Chemours Provides update on Internal Review
9:28pm
8-K
6xrsfw6
29 Feb 24
Results of Operations and Financial Condition
8:17am
8-K
1cvfbllzxd
29 Feb 24
Departure of Directors or Certain Officers
8:14am
8-K/A
p3br kcc1ukbk9bx
16 Feb 24
Departure of Directors or Certain Officers
4:17pm
8-K
sfl8nukm7wzazviwy8u
16 Feb 24
Chemours Announces Changes to its Board of Directors
4:16pm
8-K
lupvxi4f01nlzv5h93j
13 Feb 24
Chemours Reschedules Earnings Release and Conference Call
4:19pm
8-K
6u9yeudfx6vs9y2eoa
29 Nov 23
Chemours Announces Settlement Agreement with State of Ohio
6:49am
8-K
02qiii9d
22 Nov 23
The Chemours Company Announces Changes to its Board of Directors
4:11pm
8-K
krahej
26 Oct 23
The Chemours Company Announces Third Quarter 2023 Results
4:20pm
8-K
mhe2 p24lyw
23 Aug 23
Entry into a Material Definitive Agreement
5:23pm
8-K
djrzi
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am
8-K
oad0m6
27 Jul 23
The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan
9:01pm
8-K
bp96w 0h5gx4m
26 Jul 23
Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions
7:47am
8-K
lno3f
30 Jun 23
Entry into a Material Definitive Agreement
4:30pm